Literature DB >> 12237322

Inhibition of bcl-x(l) phosphorylation by tea polyphenols or epigallocatechin-3-gallate is associated with prostate cancer cell apoptosis.

Aslamuzzaman Kazi1, David M Smith, Qing Zhong, Q Ping Dou.   

Abstract

Prostate cancer cells demonstrate slow growth kinetics and chemoresistance. Tea polyphenols have been shown to exert prostate cancer-preventative effects. Here we report that growth-arrested prostate cancer cells expressed high levels of a hyperphosphorylated Bcl-X(L) in mitochondria. Treatment with tea polyphenols or the major tea component epigallocatechin-3-gallate blocked expression of the hyper-, but not hypophosphorylated Bcl-X(L) in mitochondria, accompanied by cytochrome c release, caspase activation, and apoptosis. Studies using specific inhibitors suggest that tea inhibits p38 mitogen-activated protein kinase and the proteasome activities, leading to inhibition of Bcl-X(L) phosphorylation and induction of prostate cancer cell death.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12237322     DOI: 10.1124/mol.62.4.765

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  10 in total

1.  Structural studies of Bcl-xL/ligand complexes using 19F NMR.

Authors:  Liping Yu; Philip J Hajduk; Jamey Mack; Edward T Olejniczak
Journal:  J Biomol NMR       Date:  2006-04       Impact factor: 2.835

2.  The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner.

Authors:  Aslamuzzaman Kazi; Jiazhi Sun; Kenichiro Doi; Shen-Shu Sung; Yoshinori Takahashi; Hang Yin; Johanna M Rodriguez; Jorge Becerril; Norbert Berndt; Andrew D Hamilton; Hong-Gang Wang; Saïd M Sebti
Journal:  J Biol Chem       Date:  2010-12-09       Impact factor: 5.157

Review 3.  Green tea polyphenols as proteasome inhibitors: implication in chemoprevention.

Authors:  H Yang; K Landis-Piwowar; T H Chan; Q P Dou
Journal:  Curr Cancer Drug Targets       Date:  2011-03       Impact factor: 3.428

Review 4.  New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer.

Authors:  Shahnjayla K Connors; Ganna Chornokur; Nagi B Kumar
Journal:  Nutr Cancer       Date:  2011-11-18       Impact factor: 2.900

5.  Down-regulation of Bcl-XL by RNA interference suppresses cell growth and induces apoptosis in human esophageal cancer cells.

Authors:  Yong-En Xie; En-Jie Tang; Da-Rong Zhang; Bi-Xuan Ren
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

6.  Modulation of protein phosphatase 2A activity alters androgen-independent growth of prostate cancer cells: therapeutic implications.

Authors:  Arun Bhardwaj; Seema Singh; Sanjeev K Srivastava; Richard E Honkanen; Eddie Reed; Ajay P Singh
Journal:  Mol Cancer Ther       Date:  2011-03-10       Impact factor: 6.261

Review 7.  Tea polyphenols, their biological effects and potential molecular targets.

Authors:  D Chen; V Milacic; M S Chen; S B Wan; W H Lam; C Huo; K R Landis-Piwowar; Q C Cui; A Wali; T H Chan; Q P Dou
Journal:  Histol Histopathol       Date:  2008-04       Impact factor: 2.303

Review 8.  Green tea and the risk of prostate cancer: A systematic review and meta-analysis.

Authors:  Yuming Guo; Fan Zhi; Ping Chen; Keke Zhao; Han Xiang; Qi Mao; Xinghuan Wang; Xinhua Zhang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

9.  PINK1 protects against cell death induced by mitochondrial depolarization, by phosphorylating Bcl-xL and impairing its pro-apoptotic cleavage.

Authors:  G Arena; V Gelmetti; L Torosantucci; D Vignone; G Lamorte; P De Rosa; E Cilia; E A Jonas; E M Valente
Journal:  Cell Death Differ       Date:  2013-03-22       Impact factor: 15.828

Review 10.  Phytochemical modulators of mitochondria: the search for chemopreventive agents and supportive therapeutics.

Authors:  Maja M Grabacka; Malgorzata Gawin; Malgorzata Pierzchalska
Journal:  Pharmaceuticals (Basel)       Date:  2014-09-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.